Zaleplon Capsule
Product Images NDC 43063-912

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zaleplon (NDC 43063-912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063912 Label (43063912)

43063912 Label (43063912)
Zaleplon USP 10 mg oral capsules label from PD-Rx Pharmaceuticals, Inc. The label shows a 10 capsule package with a red and white design, including the NDC number 43063-912-10. It features dosage strength, quantity, lot number L18A55, expiration 05/20, and directions space for daily intake. The label cautions keeping out of children’s reach and includes contact info for reporting side effects to the FDA.*
FDA Label Image

Chem

Chem
Chemical structure of Zaleplon, showing its molecular components including a pyrimidine ring fused with an indole group and additional functional groups such as an acetamide moiety and ethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.